GSS — Genetic Signatures Cashflow Statement
0.000.00%
Last trade - 00:00- AU$19.31m
- -AU$2.48m
- AU$20.32m
Annual cashflow statement for Genetic Signatures, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.126 | 0.565 | 0.483 | 1.23 | 0.829 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 9.81 | -12.5 | -10.1 | -12.3 | -7.77 |
| Capital Expenditures | -2.99 | -8.09 | -4.79 | -0.902 | -1.05 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | -23.4 | 10.9 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.99 | -8.09 | -4.79 | -24.3 | 9.85 |
| Financing Cash Flow Items | -0.009 | -0.001 | -2.53 | -0.554 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.101 | -0.023 | 34.8 | 7.79 | -0.481 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.78 | -20.5 | 19.9 | -28.8 | 1.59 |